Login
About Alexion
Our Leadership
Our Partnerships
Our Ethical Standards
Our History
Patient Focus
Advocacy
Patient Stories
Products
Soliris
®
PNH
aHUS
Strensiq
®
Kanuma
®
Research & Development
Our Pipeline
Development Programs
Investigator-Sponsored Research
Discovery Partnerships
Responsibility
Global Access to Medicines Policy
Main Menu
Careers
Job Opportunities
Why Choose Alexion
Culture
Compensation & Benefits
Work/Life Balance
Health & Wellness
Financial Security
Recognition & Rewards
Personal Growth & Development
Professional Development
Select a Country
North America
Canada
USA
Latin America
Argentina
Brazil
Colombia
Mexico
Europe, the Middle East & Africa
Alexion Europe
Belgium
Denmark
France
Germany
Ireland
Italy
Netherlands
Norway
Russia
Spain
Sweden
Switzerland
Turkey
UAE
UK
Asia Pacific
Australia
China
India
Japan
Investors
News
Contact
Select a Country
Investors
News
Contact
Search for:
North America
Canada
United States
Latin America
Argentina
Brazil
Colombia
Mexico
Europe, the Middle East & Africa
Alexion Europe
Belgium
Denmark
France
Germany
Ireland
Italy
Netherlands
Norway
Russia
Spain
Sweden
Switzerland
Turkey
UAE
United Kingdom
Asia Pacific
Australia
China
India
Japan
About Alexion
Patient Focus
Products
Research & Development
Responsibility
Careers
Select a Country
North America
Canada
USA
Latin America
Argentina
Brazil
Colombia
Mexico
Europe, the Middle East & Africa
Alexion Europe
Belgium
Denmark
France
Germany
Ireland
Italy
Netherlands
Norway
Russia
Spain
Sweden
Switzerland
Turkey
UAE
UK
Asia Pacific
Australia
China
India
Japan
Investors
News
Contact
Home
»
Newsroom
»
Press Releases
Press Releases
Press Releases
Filter by Category
All Press Releases
Company Releases
Company Statements
Financial Releases
Product Releases
Sort by Year
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
Media
Inquiries
Media
Materials
Email
Alerts
All News Releases
Search:
Alexion Pharmaceuticals Purchases Biopharmaceutical Manufacturing Site in Rhode Island
July 13, 2006
HTML
PDF
Alexion Pharmaceuticals Appoints David L. Hallal Vice President U.S. Commercial Operations
July 6, 2006
HTML
PDF
Alexion Announces the EXPLORE Clinical Diagnostic Study for Paroxysmal Nocturnal Hemoglobinuria (PNH)
June 16, 2006
HTML
PDF
Alexion Pharmaceuticals Reports Positive Interim Safety and Efficacy Results for Soliris(TM) (eculizumab) From the Open-Label Phase III SHEPHERD Safety Trial in Paroxysmal Nocturnal Hemoglobinuria Patients
June 12, 2006
HTML
PDF
ALEXION Announces Pre-Clinical Results with Novel Anti-Cancer Antibody; Treatment Against New Potential Cancer Target Found to Stop Leukemia Tumor Growth
June 6, 2006
HTML
PDF
Alexion Announces Pre-Clinical Results with Novel Anti-Cancer Antibody; Treatment Against New Potential Cancer Target Found to Stop Leukemia Tumor Growth
June 6, 2006
HTML
PDF
ALEXION Pharmaceuticals™ Antibody Therapy Shown Effective in Model for Severe Allergic Asthma
May 15, 2006
HTML
PDF
Alexion Pharmaceuticals™ Antibody Therapy Shown Effective in Model for Severe Allergic Asthma
May 15, 2006
HTML
PDF
Alexion Pharmaceuticals Reports First Quarter 2006 Results
April 27, 2006
HTML
PDF
Alexion To Present At Investor Conferences
April 25, 2006
HTML
PDF
« first
‹ previous
…
38
39
40
41
42
43
44
45
46
next ›
last »
